Loading organizations...
§ Private Profile · Basking Ridge, NJ, USA
Bioelectronic medicine commercializing nVNS neuromodulation therapy via gammaCore for pain, cluster headache, and migraine.
Based in Basking Ridge, New Jersey, electroCore is a commercial-stage bioelectronic medicine company that develops and distributes non-invasive vagus nerve stimulation therapies to treat chronic pain and related conditions. The publicly traded organization focuses on addressing complex neurological and metabolic disorders, providing alternative neuromodulation treatments for patients suffering from episodic cluster headaches, migraines, and post-concussion symptoms. Operating under the Nasdaq exchange ticker ECOR, the enterprise maintains a robust intellectual property portfolio consisting of over 200 patents and pending applications worldwide for its proprietary technology. The firm's flagship gammaCore system recently secured formal reimbursement approval from the Belgian national health insurance institute RIZIV/INAMI, while simultaneously undergoing active clinical evaluation for post-traumatic stress disorder. electroCore was officially founded in 2005 by the collaborative team of JP Errico, Thomas J. Errico, Charles Theofilos, and Peter Staats.
electroCore has raised $120.0M across 2 funding rounds.
electroCore has raised $120.0M in total across 2 funding rounds.
electroCore has raised $120.0M in total across 2 funding rounds.
electroCore's investors include Core Ventures Group, American Investment Holdings, Gakasa, Merck, Vinik Family Foundation, Easton Capital.
electroCore has raised $120.0M across 2 funding rounds. Most recently, it raised $70.0M Series B in November 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 29, 2017 | $70M Series B | Core Ventures Group | American Investment Holdings, Gakasa, Merck, Vinik Family Foundation | Announced |
| Jul 1, 2014 | $50M Venture Round | — | Core Ventures Group, Easton Capital, Merck | Announced |